000 | 01280 a2200337 4500 | ||
---|---|---|---|
005 | 20250517083122.0 | ||
264 | 0 | _c20160630 | |
008 | 201606s 0 0 eng d | ||
022 | _a1941-3084 | ||
024 | 7 |
_a10.1161/CIRCEP.115.002479 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHanley, Colleen M | |
245 | 0 | 0 |
_aStatus of Antiarrhythmic Drug Development for Atrial Fibrillation: New Drugs and New Molecular Mechanisms. _h[electronic resource] |
260 |
_bCirculation. Arrhythmia and electrophysiology _cMar 2016 |
||
300 |
_ae002479 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAction Potentials |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xadverse effects |
650 | 0 | 4 |
_aAtrial Fibrillation _xdiagnosis |
650 | 0 | 4 |
_aDrugs, Investigational _xadverse effects |
650 | 0 | 4 |
_aHeart Conduction System _xdrug effects |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aRobinson, Victoria M | |
700 | 1 | _aKowey, Peter R | |
773 | 0 |
_tCirculation. Arrhythmia and electrophysiology _gvol. 9 _gno. 3 _gp. e002479 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCEP.115.002479 _zAvailable from publisher's website |
999 |
_c25790372 _d25790372 |